Champions Oncology
CSBR
32 hedge funds and large institutions have $47.8M invested in Champions Oncology in 2019 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 9 increasing their positions, 10 reducing their positions, and 6 closing their positions.
48% more capital invested
Capital invested by funds: $32.4M → $47.8M (+$15.4M)
0.04% more ownership
Funds ownership: 49.33% → 49.36% (+0.04%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
3% less funds holding
Funds holding: 33 → 32 (-1)
10% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 10
17% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CPA
Cowen Prime Advisors
New York
|
+$948K |
| 2 |
MAG
Millrace Asset Group
Berwyn,
Pennsylvania
|
+$615K |
| 3 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$568K |
| 4 |
TAM
Tocqueville Asset Management
New York
|
+$432K |
| 5 |
EIM
Essex Investment Management
Boston,
Massachusetts
|
+$221K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wells Fargo
San Francisco,
California
|
-$870K |
| 2 |
GIP
Granite Investment Partners
El Segundo,
California
|
-$579K |
| 3 |
OAM
Oberweis Asset Management
Lisle,
Illinois
|
-$307K |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
-$207K |
| 5 |
WCM
Wedge Capital Management
Charlotte,
North Carolina
|
-$200K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
TRCT
26
Tower Research Capital (TRC)
New York
| $15K | -$3.51K | -568 | -23% |
|
27
UBS Group
Zurich,
Switzerland
| $12K | +$8.63K | +1,398 | New |
|
|
PAM
28
Panagora Asset Management
Boston,
Massachusetts
| $4K | – | – | – |
|
29
Royal Bank of Canada
Toronto,
Ontario, Canada
| $2K | -$31 | -5 | -3% |
|
|
APC
30
Aspire Private Capital
Cornelius,
North Carolina
| $2K | – | – | – |
|
|
GIP
31
Granite Investment Partners
El Segundo,
California
| – | -$579K | -102,501 | Closed |
|
|
OAM
32
Oberweis Asset Management
Lisle,
Illinois
| – | -$307K | -54,333 | Closed |
|
|
WCM
33
Wedge Capital Management
Charlotte,
North Carolina
| – | -$200K | -35,438 | Closed |
|
|
SSB
34
Sandy Spring Bank
Olney,
Maryland
| – | -$148K | -26,250 | Closed |
|
|
PCM
35
Prelude Capital Management
New York
| – | -$19K | -3,360 | Closed |
|
36
Victory Capital Management
San Antonio,
Texas
| – | -$6K | -1,150 | Closed |
|
|
LTFS
37
Ladenburg Thalmann Financial Services
Miami,
Florida
| – | -$25 | -4 | -25% |
|
CSBR Hedge Fund Activity: Q4 2019 in Review
32 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Champions Oncology (CSBR) for Q4 2019, worth a combined $47.8M — up 48% from $32.4M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of CSBR and 5 opened new positions — a net loss of 1 holder — while 10 trimmed existing stakes and 9 added.
The largest buyer was Cowen Prime Advisors, opening a new position worth an estimated $948K. The largest seller was Wells Fargo, cutting an estimated $870K.
- 32 institutional investors held Champions Oncology (CSBR) as of Q4 2019, down from 33 in Q3 2019.
- Funds reported $47.8M of Champions Oncology stock for Q4 2019, up 48% quarter-over-quarter.
- 5 funds opened new Champions Oncology positions in Q4 2019 and 6 closed out, a net change of -1 holder.
- The largest Champions Oncology buyer in Q4 2019 was Cowen Prime Advisors, an estimated $948K added.
- The largest Champions Oncology seller in Q4 2019 was Wells Fargo, an estimated $870K sold.
Based on aggregated 13F filings for Q4 2019.